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 The successful creation of a living blood vessel substitute for bypass surgery can 
overcome current problems associated with grafting the patient’s own vascular tissue. A 
fully biological vessel comprised of smooth muscle cells (SMC's) in collagen is an 
attractive alternative due to its potential for long-term remodeling and vasoactivity, but 
these vessels are limited by inherent physical weaknesses. This study determines how the 
mechanical properties of tissue engineered blood vessels made with the collagen/SMC 
method can be improved by biochemical stimulation. Vessels were prepared by 
embedding rat aortic smooth muscle cells in a collagen gel and culturing the constructs 
for two weeks to allow matrix remodeling. Experimental vessels were treated with 
transglutaminase and cultured in media supplemented with ascorbic acid, TGF-beta, and 
insulin. Mechanical properties of these vessels were measured by using tensile testing of 
ring samples from the vessels and applying internal pressure loads over whole constructs. 
The treated vessels demonstrated statistically significant improvements in both ultimate 
tensile strength and burst pressure relative to control vessels. These results indicate that 







 Approximately half a million coronary artery bypass surgeries are performed in 
the United States each year.[1] This procedure is done when a patient’s coronary arteries 
have narrowed to where blood flow is significantly reduced and a heart attack is either 
imminent or has already occurred. Typically, the narrowed artery is bypassed by using a 
graft of vascular tissue from elsewhere in the patient’s body. The practice of using tissue 
grafts, however, is not always possible since the patient’s other vessels might be 
unavailable due to previous surgery, or because they are also diseased. As a result, efforts 
are being made in the field of tissue engineering to successfully make implantable blood 
vessel substitutes that do not require native tissue from the patient.  
 There are several requirements for a successful tissue engineered blood vessel 
(TEBV). It must be immunologically safe, meaning the patient's immune system will not 
reject the implant. The interior surface of the vessel that contacts blood needs to be non-
thrombogenic, which means that it should not cause unwanted blood clots. The vessel 
should also be mechanically strong enough to withstand blood pressures in vivo. Lastly, 
an ideal small-diameter substitute is able to demonstrate the vasoactivity of native blood 
vessels, meaning it can dilate or constrict when prompted.[1]  
 
Overview of Current State 
 Several technologies for engineering a blood vessel substitute are being 
investigated. Approaches that involve synthetic grafts or scaffolds tend to yield vessels 
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that are more mechanically stable, but the non-biological components of these vessels 
place limitations on their ability to be successfully incorporated into a human's 
circulatory system. Engineered vessels that consist solely of biological components, such 
as cells and extracellular matrix (ECM) proteins, are better suited for demonstrating 
vasoactivity, but to date they have failed to be physically strong enough to withstand 
blood pressure in the body. This literature review will focus on a particular method of 
engineering fully biological blood vessels constituted of smooth muscle cells (SMC’s) 
and collagen, as well as the efforts being made to improve the vessels' mechanical 
properties. 
 
The Collagen-Based Approach 
 The collagen-based model for engineering blood vessel substitutes is comprised 
of vascular SMC’s embedded in a collagen gel matrix. This model roughly mimics the 
structure of the media, or middle layer, of native blood vessels. The primary advantage of 
the collagen-based approach is that the biological nature of the collagen matrix allows the 
cells to remodel the construct during culture time and promote functional vasoactivity 
demonstrated by a normal blood vessel. In addition, the interior surface of these vessels 
can presumably be lined with endothelial cells, like native vessels, so that they will not be 
thrombogenic. The major issue that arises with this model, however, is that collagen gels 
have an inherent physical weakness that can limit their ability to withstand in vivo blood 
pressure. Although a synthetic reinforcement can be used to increase the engineered 
vessel’s strength, this additional structural component places limits on the construct’s 
ability to undergo biological adaptation. As a result, research focuses on finding ways to 
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improve the mechanical strength of TEBV’s made with the collagen-based model without 
the use of a synthetic support.[1]  
 
Mechanical and Biochemical Stimulation 
 Dynamic mechanical conditioning of the collagen/SMC vessels has shown 
promise as a technique for improving the physical strength of the vessels. In a study by 
Seliktar et al, the constructs were cultured around a silicon sleeve and subjected to 
circumferential strain that cycled between 0% and 10% at a frequency of 1 Hz. In other 
words, the interior of the sleeve was pressurized and depressurized such that the diameter 
of the construct would vary between its original value and 10% greater. The conditioned 
constructs exhibited a significant increase in yield stress and ultimate stress when 
uniaxial mechanics were tested by cutting the vessel into rings and stretching the rings 
until failure.[2] In a later study by Syedain et al., the applied periodic strain was increased 
in four steps from 5% to 15% over a 3 week period. This method of conditioning, called 
incremental cyclic distension (ICD), further improved the mechanical strength of the 
vessels relative to vessels that cycled between the static values for the entire 3 weeks.[3] 
Thus, applying mechanical stress to constructs as they are cultured helps to overcome the 
strength limitations that currently hinder the collagen/SMC model.  
 Biochemical stimulation can be used to favorably affect the cell-mediated 
remodeling that occurs when collagen constructs are cultured. Tissue transglutaminase 
(TG) is an enzyme that cross-links collagen gels by catalyzing the formation of an amide 
bond between glutamine and lysine residues in the polypeptide chains of collagen 
fibers.[4] This reaction, which is dependent on the presence of Ca
+2
 ions, has been shown 
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by Orban et al. to significantly increase the burst pressure of collagen constructs without 
being toxic to the smooth muscle cells.[5] The researchers of this study, however, 
acknowledged that burst pressure tests are only a simple comparison of strength that do 
not take into account dimensions and fail to give information on axial mechanics. Also, 
these constructs were only cultured for 7 days, while Girton et al. found that it takes 
about 14 days for them to fully remodel.[6] Thus, the data from this study may not 
accurately represent burst pressures of the engineered vessels in their mature form. 
 Ascorbic acid (AA) is known to stimulate SMC’s to produce more extracellular 
matrix, and a correlated improvement in uniaxial ultimate tensile stress (UTS) occurred 
when the culture media for constructs was supplemented with AA by Ogle et al.[7] 
Insulin similarly causes increased collagen production in vascular SMC’s,[8] so it could 
potentially be beneficial to improving the strength of collagen TEBV's. However, the 
effects of insulin in tissue engineering applications have yet to be thoroughly explored.   
 Transforming growth factor beta (TGF-beta) causes phenotypic changes in 
SMC’s that are not yet fully understood but can lead to favorable extracellular matrix 
remodeling as the cells in constructs compact the collagen gel. Consequently, blood 
vessel constructs cultured in media containing TGF-beta experience a higher degree of 
gel compaction and exhibit a histologically more dense matrix.[9] This means TGF-beta 
may also be useful in improving the mechanics of the collagen/SMC engineered vessels.  
 
Summary 
 It has been established that certain biochemical factors can cause improvement in 
the mechanical integrity of TEBV’s made with the collagen gel approach.  There is not, 
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however, significant knowledge on the effects of using these previously identified 
treatments (TG, AA, TGF-beta, and insulin) in combination with each other. It is 
unknown if all of the treatments together can exhibit mechanical improvements beyond 
what the individual treatments accomplish, or if similarities in the mechanisms of action 
result in negligible benefits of adding more biochemical factors.  Evidence at least exists 
for a synergistic relationship between TGF-beta and insulin,[10] but for several 
treatments the effects are unknown.  
 Comprehensive quantification of the favorable changes in mechanical properties 
is also lacking. Employing multiple testing methods will give a more complete evaluation 
of mechanical properties. Ring tests can be used as a relatively simple method of testing 
tensile properties,[11] and particle tracking on these tests are useful to analyze true local 
strain.[2] Since blood pressure is a load applied to vessels in vivo, circumferential 
mechanics are important factors to consider and can be assessed using pressure vs. 
diameter tests intended to simulate conditions within the body.  
 Thus, the goal of this project on collagen-based TEBV’s is to research a new 
experimental group of biochemical treatments, consisting of TG, TGF-beta, AA, and 
insulin, using a more diverse mechanical testing approach that includes both uni-
directional tension and internal pressure loads. Blood vessel constructs were fabricated by 
embedding rat aortic smooth muscle cells (RASMC’s) in a type I bovine collagen gel, 
then allowing the constructs to compact for two-weeks in culture media. For the 
experimental constructs, the gel contained TG and the culture media was supplemented 
with AA, insulin, and TGF-β. Unidirectional mechanics and tensile strength were 
evaluated using ring samples from the constructs, and internal pressures were applied to 
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whole constructs for burst pressure, creep, and fatigue experiments.  The data for 
experimental and control constructs were compared to determine the changes caused by 




MATERIALS AND METHODS 
 
 
Cell Culture  
  Rat aortic smooth muscle cells (RASMC) were cultured in a monolayer in 
Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 2 mM L-glutamine, 
100 U/ml penicillin, 100 ug/ml streptomycin, and 10% fetal bovine serum (FBS) at 
standard cell culture conditions (37° C, 5% CO2). Detachment and seeding of the cells 
was accomplished using phosphate-buffered saline (PBS) and 0.05% trypsin.   
 
Collagen Construct Preparation 
 Bovine collagen type I was dissolved to a concentration of 4 mg/ml in 0.02 N 
acetic acid. The construct mixture was prepared by first mixing 5X DMEM and 0.1 M 
NaOH such that the complete mixture would had a 1:4 volume ratio of  5X DMEM: 
collagen solution, and 1:6 ratio of NaOH: collagen solution. The collagen solution was 
then added to the DMEM-NaOH mixture so that the final concentration of collagen 
would be 2 mg/ml. Lastly, a cell suspension in 1X DMEM was added to make the cell 
concentration 10
6
 cells/ml in the complete mixture. 
 For constructs treated with TG (experimental constructs), a 5000:1 weight ratio of 
collagen:TG was used in the complete construct mixture, since this has been found to be 
the optimal concentration.[5] Also in accordance with the Orban study, the construct 
mixture contained 2.5 mM CaCl2 and 1 mM dithiothreitol (DTT).   
 The complete construct mixture was pipetted into test tubes at 5 to 7 ml per tube, 
then a glass mandrel was inserted into each tube. Gels were allowed to solidify about the 
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central mandrel in the cell culture incubator for approximately 45 minutes, after which 
they were removed and placed in the DMEM solution previously described (see Figure 
1). The culture media for the experimental constructs contained 2 ug/ml of insulin, 1 
ng/ml of TGF-beta, and 50 ug/ml of Ascorbic Acid in accordance with the studies listed 
in the background section. The gels were cut away from the rubber ends of the central 
mandrel so that they could compact freely. Vessels were cultured in the conditions 
previously described with media being changed weekly and the experimental media 
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 Constructs were tested 14 days after being made since research has found that no 
significant gel compaction or remodeling occurs after this time.[6] Rings with a length of 
approximately 4 mm were cut from the construct and given a light dusting of black 
carbon powder so that particle tracking could eventually be done on pictures taken during 
the tests.   
 The ring tests were conducted in PBS using the testing apparatus in Dr. Nerem's 
lab. The testing device recorded the load and displacement of the two hooks on which the 
rings are pulled (see Figures 3 and 4). After being preconditioned by 5 stretches to 1 mm 
greater the unstretched length, the construct rings were stretched to failure at constant 
displacement rates of either 0.1 mm/s or 1 mm/s. Two cameras record images during the 
tests: one from the front of the ring and another from the side. Nominal stress and strain 
measurements for the construct rings were calculated using the load and extension 
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measurements taken by the testing equipment. The geometric dimensions of the rings in 
the unloaded state were found by referencing the length and thickness of the rings in the 
camera images with the testing hooks (which have a known diameter). Average ultimate 
tensile strength (UTS), which is the maximum stress sustained before tearing, was 
calculated for each treatment group and displacement rate.  
 











 For pressure testing, each end of the whole construct was slid onto a metal tube 
and secured using suture thread (see Figure 5). The testing set-up was a fluid “circuit” of 
PBS consisting of the following items in a loop: (1) a partially filled, stopper-sealed 
Erlenmeyer flask with several leads for tube connections, (2) a pressure transducer, (3) 
the construct in a bath of PBS, and (4) a second pressure transducer. The fluid pressure in 
the system was controlled by clamping shut one tube leading to the flask, then modifying 
the pressure in the air space above the fluid in the flask. The average of the two pressure 
readings was taken to be the pressure inside the construct. Burst pressure was measured 
by increasing the internal pressure at a constant rate, then recording the maximum 
pressure sustained before rupture.   
 





 Ring tests and burst pressure tests were used to quantify the mechanical properties 
of the biochemically treated vessels as compared to the control vessels.  
 
Ring Tests 
 The results from ring tests are displayed in Figure 6. The control group consisted 
of engineered vessels made according to the standard protocol, while the treated group 
consisted of constructs that were treated with transglutaminase and cultured in media 
containing ascorbic acid, TGF-beta, and insulin. The number at the top of the graph is the 
rate at which the rings were stretched until failure, either 0.1 mm/s or 1 mm/s. Each of the 
four bars represents a sample size of N=6, and results are plotted as mean ± standard 
error. At an extension rate of 0.1 mm/s, treated constructs had an average ultimate tensile 
strength (UTS) of 107 ± 4 kPa while control constructs had an average UTS of 60 ± 3 
kPa.  At an extension rate of 1 mm/s, treated constructs had an average UTS of 133 ± 7 
kPa while control constructs had an average UTS of 70 ± 4 kPa. For both extension rates, 
the difference between treated and control constructs was statistically significant (p = 










Burst Pressure Tests 
 The results from the burst pressure tests are displayed in Figure 7. The control and 
treated groups had the same conditions as described in the previous section. The sample 
size for the control group was N = 8, while the sample size for the treated group was N = 
5. Treated constructs had an average burst pressure of 211 ± 10 mmHg while control 
constructs had an average burst pressure of 144 ± 6 mmHg. This difference was 













 The results indicate that treatment with TG, AA, insulin, and TGF-beta 
significantly improves the mechanical properties of engineered blood vessel constructs 
consisting of SMC's in collagen. Compared to control vessels, the treated vessels were 
able to withstand greater applied loads before rupturing during both tensile and pressure 
testing.   
 Compared to constructs in other studies treated only with TG and cultured for 7 
days, the vessels in this experiment were substantially stronger based on the results of 
burst pressure experiments. Orban et al. reported that constructs treated with TG had an 
average burst pressure of 71 ± 4 mmHg after 7 days.[5] In comparison, vessels in this 
experiment that were treated with TG in addition to AA, TGF-beta, and insulin had an 
average burst pressure of 211 ± 10 mmHg after 14 days. Thus, the additional culture time 
combined with the three additional biochemical treatments results in further 
improvements in mechanical strength.  
  The primary take-away from this project is that biochemical stimulation of 
collagen-based blood vessel constructs seeded with smooth muscle cells produces 
favorable changes in the mechanical properties of the tissue. The strength of vessels that 
are treated with the four factors of interest in this study, however, remains insufficient for 
these vessels to be used as tissue substitutes for applications such as bypass surgery. The 
human saphenous vein, which is typically used as the substitute vessel during bypass 
surgery, has a burst pressure that is roughly one order of magnitude greater, in the range 
of 1,680 to 2,273 mmHg.[12] Additional strengthening techniques such as mechanical 
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conditioning are required if the collagen/SMC engineered vessels will ever be feasible as 
replacement grafts, but biochemical stimulation is a technique that can help meet the 
requirements for mechanical strength. Once these vessels can be engineered to have the 
necessary mechanical integrity, researchers will be one step closer to manufacturing 







 Characterization of biological and/or structural changes caused by these factors 
will lead to a better understanding of the mechanisms by which the strength has been 
improved. Collagen content of the vessels may be increased due to ascorbic acid and 
insulin stimulating the SMC's to produce more ECM. The extent of crosslinking should 
also be greater in constructs that have been treated with TG. TGF-beta has previously 
been shown to lead to greater compaction of the vessels, so the structure of the treated 
vessels will presumably be denser than that of untreated vessels. These hypotheses should 
be tested with the appropriate biological assays to confirm that the chemicals are 
inducing the expected changes.  
 Increasing the number of experimental groups will reveal more information about 
which of the biochemical treatments are the most beneficial to mechanical strength. This 
experiment only used a control group with none of the treatments and an experimental 
group with all four of the treatments, under the expectation that future work will test 
mechanical properties when only one, two, or three of the treatments are used. At the 
very least, repeating these methods on a group with just TG and a group with just the 
soluble factors in the culture media will give insight to their relative contributions. 
Ideally, there would be 16 (2
4
) experimental groups so that all possible combinations of 
treatments are used. Data can then be analyzed with ANOVA to see the effects of each 
treatment so that researchers will know which factors are the most promising. 
 A wider variety of pressure tests should also be conducted to more 
comprehensively analyze vessel mechanics. The burst pressure experiments in this study, 
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which increased pressure until vessel failure, were a relatively simple way to assess 
strength. Vessels in vivo, however, experience pressures that oscillate between systolic 
and diastolic blood pressures. Thus, a more appropriate mechanical test would cycle the 
internal pressure between an upper and lower value and analyze the deformation of the 
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